CELECOXIB-D7
|
|
|
- CAS-Nr.
- 544686-21-7
- Englisch Name:
- CELECOXIB-D7
- Synonyma:
- CELECOXIB-D7;Celecoxiβ-d7;[2H7]-Celecoxib;4-[5-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;Celecoxib D7Q: What is
Celecoxib D7 Q: What is the CAS Number of
Celecoxib D7 Q: What is the storage condition of
Celecoxib D7 Q: What are the applications of
Celecoxib D7
- CBNumber:
- CB5388385
- Summenformel:
- C17H7D7F3N3O2S
- Molgewicht:
- 388.42
- MOL-Datei:
- Mol file
|
CELECOXIB-D7 Eigenschaften
- storage temp.
- Store at -20°C
- Löslichkeit
- DMSO: 76 mg/ml,Ethanol: 33 mg/ml
- Aggregatzustand
- A solid
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
CELECOXIB-D7 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Celecoxib-d
7 is intended for use as an internal standard for the quantification of celecoxib by GC- or LC-MS. Celecoxib is a selective inhibitor of COX-2 (IC
50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively). It displays chemopreventive activity in multiple tumor types
via proapoptotic effects that are independent of COX-2 inhibition. Formulations containing celecoxib have been used in the treatment of inflammation while circumventing the gastrointestinal toxicity associated with traditional non-sterodial anti-inflammatory drugs, however, the use of celecoxib has been tempered due to its ability to induce adverse cardiovascular events.
CELECOXIB-D7 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
CELECOXIB-D7 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 67)Lieferanten
- CELECOXIB-D7
- 4-[5-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- [2H7]-Celecoxib
- Celecoxib D7Q: What is
Celecoxib D7 Q: What is the CAS Number of
Celecoxib D7 Q: What is the storage condition of
Celecoxib D7 Q: What are the applications of
Celecoxib D7
- Celecoxiβ-d7
- 544686-21-7
- C17H7D7F3N3O2S
